510(k) device
Vitalograph Model 6000 Alpha
Vitalograph Ireland, Ltd. · Spirometer, Diagnostic (BZG, Class II) · First FDA decision Jun 4, 2008, newest Jan 26, 2022AsthmaCOPD and emphysema
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
510(k) pathway
Device trials
2
Naming "Vitalograph"
MAUDE reports
0
Brand "Vitalograph", since 2015
PubMed studies
190
Mentioning "Vitalograph"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vitalograph Model 6000 Alpha
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
K212938 · Decided Jan 26, 2022 · 133 days after receipt
Device type: Spirometer, Diagnostic (BZG) · Anesthesiology & Respiratory
K200550 · Decided Jul 27, 2020 · 146 days after receipt
Device type: Spirometer, Diagnostic (BZG) · Anesthesiology & Respiratory
K160253 · Decided Aug 26, 2016 · 207 days after receipt
Device type: Spirometer, Diagnostic (BZG) · Anesthesiology & Respiratory
3 more FDA decisions with a free account
Older decisions: K073155
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vitalograph", any status and sponsor, newest update first.
Institut de Myologie, FranceAcademic, hospital or other
NCT05798325 · 40 participants · Start Jun 29, 2023 · Primary completion Jun 6, 2025
Device: Acceleromerty; Goniometry and 1 more · For: Neuromuscular Diseases
Sites: Paris, France; Newcastle upon Tyne, United Kingdom
- ATP and P2X3 Receptor in Chronic CoughStatus unknown
Imperial College LondonAcademic, hospital or other
NCT05713019 · 20 participants (planned) · Start Feb 28, 2023 · Primary completion Mar 28, 2024
Device: Adenosine triphosphate (ATP) solution inhalation from nebuliser; Recording of Cough Count and frequency using the Hyfe Cough Monitor · For: Cough
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vitalograph", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code BZG
21 reports: 16 malfunction, 5 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vitalograph"[tiab]. The summary above synthesizes these.
- Characteristics of the Vitalograph spirometer.
Drew CD, Hughes DT · Thorax · 1969
- Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care.
Dickens AP, Fitzmaurice DA, Adab P, et al. · NPJ Prim Care Respir Med · 2020Research Support, Non-U.S. Gov't
- Vitalograph emergency aspirator.
Taylor GT, Macmillan RR · Anaesthesia · 1984Letter
- Chronic periodontitis and reduced respiratory function.
Winning L, Patterson CC, Cullen KM, et al. · J Clin Periodontol · 2019Research Support, Non-U.S. Gov't
- [Use of COPD-6 Vitalograph in Primary Care as tool for smoking cessation].
Antón-García F, Pruteanu DF, Correcher-Salvador E · Semergen · 2016
- An evaluation of the vitalograph pulmonary monitor.
Perks WH, Cole M, Steventon RD, et al. · Br J Dis Chest · 1981Comparative Study
- Comparison of the Bluetooth iCOquit, piCO, and Vitalograph for the assessment of breath carbon monoxide among adults initiating smoking cessation and standardized canisters.
Tonkin S, Kezbers KM, Noble B, et al. · Drug Alcohol Depend · 2023Randomized Controlled Trial, Research Support, N.I.H., Extramural
- Performance of Vitalograph wedge-bellows spirometer--comparison with a rolling seal spirometer.
Kendrick AH, Laszlo G · Clin Phys Physiol Meas · 1991Comparative Study
- The vitalograph--a study of its role in pulmonary function testing in childhood.
Wolfsdorf J, Stevens DJ · S Afr Med J · 1971Comparative Study
- Effects of temperature on Vitalograph spirometer readings.
Perks WH, Sopwith T, Brown D, et al. · Thorax · 1983
- Quality inspection and result analysis of the spirometer calibration cylinder.
Wu Z, Peng Y, Lin K, et al. · BMC Pulm Med · 2022
- Comparison of a portable, pneumotach flow-sensor-based spirometer (Spirofyࡊ) with the vitalograph alpha Touchࡊ spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients-a randomized, crossover study.
Talwar D, Balamurugan S, Modi M, et al. · BMC Pulm Med · 2024Randomized Controlled Trial, Comparative Study
Other devices of this type
Also filed under product code BZG.
- Air Next (NVD-02)Nuvoair AB · 510(k) 2024
- ComPAS2Morgan Scientific, Inc. · 510(k) 2022
- GoSpiroMonitored Therapeutics, Inc. · 510(k) 2020
- Asthma Monitor AM3Eresearch Technology · 510(k) 2019
- SpirotelMir Medical Intl. Research Srl · 510(k) 2013
- MinispirMir Medical Intl. Research Srl · 510(k) 2012
- Chartis ConsolePulmonx, Inc. · 510(k) 2011
- Welch Allyn Cardioperfect Workstation Software (Cpws) V 1.62Welch Allyn, Inc. · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.